Hi, I need help with essay on MGT499 MOD 4 SLP. Paper must be at least 500 words. Please, no plagiarized work!This strategic plan include the induction of most innovative products backed by solid rese

Hi, I need help with essay on MGT499 MOD 4 SLP. Paper must be at least 500 words. Please, no plagiarized work!

This strategic plan include the induction of most innovative products backed by solid research of its research facilities, maintaining diversity of portfolio, cost effective and low cost medicine and achieving efficiency and effectiveness through its human and material resources. (Novartis, 2011).

The Cost Leadership component of Porter’s competitive strategies is the most important but difficult objective to be achieved especially, i

n pharmaceutical industry where quality compromise is not an option at all. The only way out to achieve competitively lower prices of products is through savings on procurements, cost effective production and advantageous use of supply chain. To ensure cost leadership the company has improved its internal processes to save production cost in order to provide relief to the consumer. ICIS, trusted market intelligence for the global chemical and energy industries states the cost effective procedures of the Novartis in these words, “Operational efficiency initiatives have made progress to improve speed, flexibility and productivity while freeing up resources. On this basis, it has launched a companywide project “Forward” to provide annual cost savings of approximately $1.6bn in 2009 and 2010.” (ICIS, n.d.).

The differentiation is mainly achieved through wide range research and diversified portfolio. Research and diversification complements each other to ensure differentiation. The company wide research facilities have contributed a long way into achieves uniqueness in its products. Afinitor, a potential breakthrough for advanced kidney cancer, the vaccine Menveo for protection against four meningococcal meningitis serogroups and Extavia (interferon beta-1b) for patients with certain forms of multiple sclerosis (MS) are few examples of thoroughly researched innovative products of Novartis to ensure a level of differentiation with its competitors. (ICIS, n.d.). The diversification of portfolio is an way